In other cancer types, such as in clear cell renal cell cancers, a higher proportion of PD-L1 expression was observed in the matched lung or lymph node metastases (33%; 27/83 patients) than in the primary tumour (24%; 20/83 patients). This evidence concerns the gene CD274 and clear cell renal carcinoma.